Global Ketorolac Injection Supply, Demand and Key Producers, 2026-2032
Description
The global Ketorolac Injection market size is expected to reach $ 1240 million by 2032, rising at a market growth of 2.6% CAGR during the forecast period (2026-2032).
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
This report studies the global Ketorolac Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ketorolac Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ketorolac Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ketorolac Injection total production and demand, 2021-2032, (K Units)
Global Ketorolac Injection total production value, 2021-2032, (USD Million)
Global Ketorolac Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Ketorolac Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Ketorolac Injection domestic production, consumption, key domestic manufacturers and share
Global Ketorolac Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Ketorolac Injection production by Concentration, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Ketorolac Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Ketorolac Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ketorolac Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/K Units) by manufacturer, by Concentration, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ketorolac Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Ketorolac Injection Market, Segmentation by Concentration:
15mg/ml
30mg/ml
Global Ketorolac Injection Market, Segmentation by Application:
Hospital
Clinics
Others
Companies Profiled:
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Key Questions Answered:
1. How big is the global Ketorolac Injection market?
2. What is the demand of the global Ketorolac Injection market?
3. What is the year over year growth of the global Ketorolac Injection market?
4. What is the production and production value of the global Ketorolac Injection market?
5. Who are the key producers in the global Ketorolac Injection market?
6. What are the growth factors driving the market demand?
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
This report studies the global Ketorolac Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ketorolac Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ketorolac Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ketorolac Injection total production and demand, 2021-2032, (K Units)
Global Ketorolac Injection total production value, 2021-2032, (USD Million)
Global Ketorolac Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Ketorolac Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Ketorolac Injection domestic production, consumption, key domestic manufacturers and share
Global Ketorolac Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Ketorolac Injection production by Concentration, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Ketorolac Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Ketorolac Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ketorolac Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/K Units) by manufacturer, by Concentration, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ketorolac Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Ketorolac Injection Market, Segmentation by Concentration:
15mg/ml
30mg/ml
Global Ketorolac Injection Market, Segmentation by Application:
Hospital
Clinics
Others
Companies Profiled:
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Key Questions Answered:
1. How big is the global Ketorolac Injection market?
2. What is the demand of the global Ketorolac Injection market?
3. What is the year over year growth of the global Ketorolac Injection market?
4. What is the production and production value of the global Ketorolac Injection market?
5. Who are the key producers in the global Ketorolac Injection market?
6. What are the growth factors driving the market demand?
Table of Contents
134 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Concentration
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
